CP 316819

Cat. No. 3542

CP 316819 C21H22ClN3O4 [186392-43-8]

Price and Availability

For CP 316819 pricing & availability please select your country from the drop down menu:
Submit
By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 5-Chloro-N-[(1S,2R)-2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide

Biological Activity

Selective glycogen phosphorylase inhibitor [IC50 values are 0.017 and 0.034 μM against human skeletal muscle glycogen phosphorylase a (huSMGPa) and liver glycogen phosphorylase a (huLGPa) respectively]. Antihyperglycemic agent.

Technical Data

M.Wt:
415.87
Formula:
C21H22ClN3O4
Solubility:
Soluble to 100 mM in DMSO and to 100 mM in ethanol
Purity:
>98 %
Storage:
Store at RT
CAS No:
186392-43-8

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.

Certificate of Analysis / Product Datasheet / Safety Datasheet

References are publications that support the products' biological activity.

Suh et al (2007) Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide). J.Pharmacol.Exp.Ther. 321 45. PMID: 17251391.

Freeman et al (2006) Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation site of the enzyme. Br.J.Pharmacol. 149 775. PMID: 17016495.

Baker et al (2005) Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes 54 2453. PMID: 16046314.

If you know of a relevant reference for CP 316819 please let us know.

Citations are publications that use Tocris products. Selected citations for CP 316819 include:

Galow et al (2014) Energy substrates that fuel fast neuronal network oscillations. J Exp Bot 8 398. PMID: 25538552.

Do you know of a great paper that uses CP 316819 from Tocris? If so please let us know.

View Related Products by Target

View Related Products by Product Action

Keywords: CP 316819, supplier, glycogen, phosphorylase, inhibitors, inhibits, antihyperglycemic, antihyperglycaemic, transferases, carbohydrate, metabolism, CP316819, Tocris Bioscience, Phosphorylase Inhibitor products

Quick Order

Find multiple products by catalog number

divider line

New Product Guide

Spring/Summer 2017

New Product Guide (Spring/Summer 2017)

Our New Product guide highlights over 130 new products added in the first half of 2017. View PDF today.

divider line

New Products in this Area

GSK 343

Potent and selective SAM-competitive EZH2 inhibitor

BRD 4770

G9a inhibitor and S-adenosyl methionine mimetic; cell permeable

Lys-CoA

Selective p300 inhibitor

UNC 2399

Biotinylated UNC 1999 (Cat.No. 4904)

PF 06726304 acetate

Highly potent and SAM-competitive EZH2 inhibitor

GSK 591 dihydrochloride

Potent and selective PRMT5 inhibitor

Sign-up for new product e-alerts
divider line

Twitter Updates

Follow @Tocris on Twitter

Follow us on Twitter!

Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.